Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wyatt

Showing results (331-340 of 345) with videos related to

Pageof 35
Sort By:
Cancer Cell|July 25, 2025
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunityAnna C Cole, Hannah M Knochelmann, Megan M Wyatt, et al.
Pediatric Pulmonology|September 25, 1999
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and CanadaW J Morgan, S M Butler, C A Johnson, et al.
BMC Infectious Diseases|July 5, 2022
Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study designC William Wester, Bryan E Shepherd, Usman J Wudil, et al.
Cancer Immunology Research|December 5, 2025
T cell priming by high avidity neoantigens in lymph nodes augments adoptive immunotherapyMegen C Wittling, Amalia M Rivera Reyes, Megan M Wyatt, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathyNatalia Papeta, Krzysztof Kiryluk, Ami Patel, et al.
Kidney International|April 26, 2021
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in NigeriaUsman J Wudil, Muktar H Aliyu, Heather L Prigmore, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.
American Journal of Physiology. Cell Physiology|August 26, 2011
Genetic deletion of trkB.T1 increases neuromuscular functionSusan G Dorsey, Richard M Lovering, Cynthia L Renn, et al.
JCI Insight|February 25, 2021
Versatile workflow for cell type-resolved transcriptional and epigenetic profiles from cryopreserved human lungMaria Llamazares-Prada, Elisa Espinet, Vedrana Mijošek, et al.
Cell Reports. Medicine|November 10, 2021
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinomaHannah M Knochelmann, Joshua D Horton, Sixue Liu, et al.
Pageof 35

Showing results (331-340 of 345) with videos related to

Sort By:
Pageof 35
Cancer Cell|July 25, 2025
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunityAnna C Cole, Hannah M Knochelmann, Megan M Wyatt, et al.
Pediatric Pulmonology|September 25, 1999
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and CanadaW J Morgan, S M Butler, C A Johnson, et al.
BMC Infectious Diseases|July 5, 2022
Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study designC William Wester, Bryan E Shepherd, Usman J Wudil, et al.
Cancer Immunology Research|December 5, 2025
T cell priming by high avidity neoantigens in lymph nodes augments adoptive immunotherapyMegen C Wittling, Amalia M Rivera Reyes, Megan M Wyatt, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathyNatalia Papeta, Krzysztof Kiryluk, Ami Patel, et al.
Kidney International|April 26, 2021
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in NigeriaUsman J Wudil, Muktar H Aliyu, Heather L Prigmore, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.
American Journal of Physiology. Cell Physiology|August 26, 2011
Genetic deletion of trkB.T1 increases neuromuscular functionSusan G Dorsey, Richard M Lovering, Cynthia L Renn, et al.
JCI Insight|February 25, 2021
Versatile workflow for cell type-resolved transcriptional and epigenetic profiles from cryopreserved human lungMaria Llamazares-Prada, Elisa Espinet, Vedrana Mijošek, et al.
Cell Reports. Medicine|November 10, 2021
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinomaHannah M Knochelmann, Joshua D Horton, Sixue Liu, et al.
Pageof 35